Tags

Type your tag names separated by a space and hit enter

Global seasonal occurrence of middle east respiratory syndrome coronavirus (MERS-CoV) infection.
Eur Rev Med Pharmacol Sci. 2018 06; 22(12):3913-3918.ER

Abstract

OBJECTIVE

Middle East Respiratory Syndrome Coronavirus (MERS-CoV) is an evolving global health crisis. Despite recent efforts, there are numerous notable gaps in the understanding of MERS-CoV seasonal diversity. We aimed at investigating the global seasonal occurrence of Middle East Respiratory Syndrome coronavirus (MERS-CoV) outbreaks.

MATERIALS AND METHODS

We obtained the data on the prevalence and occurrence of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection from the World Health Organization (WHO) for all the MERS cases reported from the various countries and their allied ministries. We also recorded the research documents published in various global scientific journals on the seasonal occurrence of MERS-CoV infection during the period 2012-2017.

RESULTS

Worldwide 2048 laboratory confirmed cases of MERS-CoV infection were reported from June 2012 to the Dec 2017. 1680 (82.03%) cases were from the Saudi Arabia and 368 (17.96%) cases were reported from the other countries of the world. The maximum number of cases reported in June was 474 (23.14%). 287 (14.01%) cases were reported from Saudi Arabia and remaining 187 (9.13%) cases were reported from all over the world. The number of cases reported from April to June was 396 (19.33%) while the cases encountered from October to December were 231 (11.27%).

CONCLUSIONS

The highest global seasonal occurrence of Middle East Respiratory Syndrome coronavirus-MERS-CoV outbreak cases were found in the month of June, while the lowest was found in the month of January during the period of 2012 to 2017. The pattern of MERS-CoV infections has been observed to have seasonal variations. It is suggested that the health officials should highlight the seasonal occurrence of MERS-CoV outbreak and take better preventive measures to minimize the disease burden nationally and globally.

Links

Publisher Full Text (DOI)

Authors+Show Affiliations

Nassar MS
King Abdulaziz City for Science and Technology (KACST), Riyadh, Saudi Arabia.
Bakhrebah MA
No affiliation info available
Meo SA
No affiliation info available
Alsuabeyl MS
No affiliation info available
Zaher WA
No affiliation info available

MeSH

Coronavirus InfectionsDisease OutbreaksGlobal HealthHumansSeasonsWorld Health Organization

Pub Type(s)

Journal Article
Observational Study
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

29949167

Citation

Nassar, M S., et al. "Global Seasonal Occurrence of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Infection." European Review for Medical and Pharmacological Sciences, vol. 22, no. 12, 2018, pp. 3913-3918.
Nassar MS, Bakhrebah MA, Meo SA, et al. Global seasonal occurrence of middle east respiratory syndrome coronavirus (MERS-CoV) infection. Eur Rev Med Pharmacol Sci. 2018;22(12):3913-3918.
Nassar, M. S., Bakhrebah, M. A., Meo, S. A., Alsuabeyl, M. S., & Zaher, W. A. (2018). Global seasonal occurrence of middle east respiratory syndrome coronavirus (MERS-CoV) infection. European Review for Medical and Pharmacological Sciences, 22(12), 3913-3918. https://doi.org/10.26355/eurrev_201806_15276
Nassar MS, et al. Global Seasonal Occurrence of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Infection. Eur Rev Med Pharmacol Sci. 2018;22(12):3913-3918. PubMed PMID: 29949167.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Global seasonal occurrence of middle east respiratory syndrome coronavirus (MERS-CoV) infection. AU - Nassar,M S, AU - Bakhrebah,M A, AU - Meo,S A, AU - Alsuabeyl,M S, AU - Zaher,W A, PY - 2018/6/28/entrez PY - 2018/6/28/pubmed PY - 2019/10/29/medline SP - 3913 EP - 3918 JF - European review for medical and pharmacological sciences JO - Eur Rev Med Pharmacol Sci VL - 22 IS - 12 N2 - OBJECTIVE: Middle East Respiratory Syndrome Coronavirus (MERS-CoV) is an evolving global health crisis. Despite recent efforts, there are numerous notable gaps in the understanding of MERS-CoV seasonal diversity. We aimed at investigating the global seasonal occurrence of Middle East Respiratory Syndrome coronavirus (MERS-CoV) outbreaks. MATERIALS AND METHODS: We obtained the data on the prevalence and occurrence of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection from the World Health Organization (WHO) for all the MERS cases reported from the various countries and their allied ministries. We also recorded the research documents published in various global scientific journals on the seasonal occurrence of MERS-CoV infection during the period 2012-2017. RESULTS: Worldwide 2048 laboratory confirmed cases of MERS-CoV infection were reported from June 2012 to the Dec 2017. 1680 (82.03%) cases were from the Saudi Arabia and 368 (17.96%) cases were reported from the other countries of the world. The maximum number of cases reported in June was 474 (23.14%). 287 (14.01%) cases were reported from Saudi Arabia and remaining 187 (9.13%) cases were reported from all over the world. The number of cases reported from April to June was 396 (19.33%) while the cases encountered from October to December were 231 (11.27%). CONCLUSIONS: The highest global seasonal occurrence of Middle East Respiratory Syndrome coronavirus-MERS-CoV outbreak cases were found in the month of June, while the lowest was found in the month of January during the period of 2012 to 2017. The pattern of MERS-CoV infections has been observed to have seasonal variations. It is suggested that the health officials should highlight the seasonal occurrence of MERS-CoV outbreak and take better preventive measures to minimize the disease burden nationally and globally. SN - 2284-0729 UR - https://www.unboundmedicine.com/medline/citation/29949167/Global_seasonal_occurrence_of_middle_east_respiratory_syndrome_coronavirus__MERS_CoV__infection_ DB - PRIME DP - Unbound Medicine ER -